Kenneth C Huber MD
Adult Congenital Heart Disease, Interventional Cardiology
Professor, Internal Medicine, University of Missouri-Kansas City School of Medicine
Join to view full profile
4330 Wornall RdSuite 2000Kansas City, MO 64111
Phone+1 816-931-1883
Fax+1 816-756-3645
Dr. Huber is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 1988 - 1991- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1985 - 1988
Saint Louis University School of MedicineClass of 1985
Certifications & Licensure
KS State Medical License 1992 - 2025
MO State Medical License 1992 - 2025
MN State Medical License 1986 - 1992
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- 44 citationsLeft Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation.Shephal K Doshi, Saibal Kar, Devi G Nair, Thomas Waggoner, Himanshu Agarwal
The New England Journal of Medicine. 2026-06-04 - 5 citationsIntracardiac vs. transesophageal echocardiography guided transcatheter closure of patent foramen ovale and atrial septal defects.Islam Shatla, Kevin Kennedy, John Thomas Saxon, Adnan K Chhatriwalla, Anthony Magalski
Cardiovascular Revascularization Medicine. 2025-08-01 - 34 citationsRationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.Saibal Kar, Shephal K Doshi, Mohamad Alkhouli, A John Camm, Megan Coylewright
American Heart Journal. 2023-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: